Delivery Order SPE2DB22D2108-SPE2DB26FU2RD
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,713.54 by the Defense Logistics Agency on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,840.88 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections, with a completion date of September 30, 2025. This firm fixed-price delivery order, issued as a non-competitive award, represents a single pharmaceutical procurement under AmerisourceBergen's broader supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,408.25 on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-competitive delivery order, with a completion date of July 29, 2025, will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract utilizes firm fixed pricing and represents a child order under a larger contract vehicle supporting federal medical procurement needs. This delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,720.90 on July 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $8,444.80 delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectables, with an ultimate completion date of September 16, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,460.82 for Mounjaro 7.5 mg/0.5 mL pens on October 27, 2025, with final completion required by October 28, 2025. This competitively awarded, firm fixed-price order represents a small-value pharmaceutical delivery supporting federal medical procurement needs. The award was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens in 0.5 mL quantities, with a ceiling value of $3,011.78. This is a firm fixed-price delivery order with no set-aside designation, scheduled for completion by October 24, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,033.03 by the Defense Logistics Agency on August 26, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,633.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens on July 18, 2025, with completion scheduled for July 21, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,492.12 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pens. The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and is scheduled for completion by July 23, 2025. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB26FU2RDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,984.16 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 31, 2025, and was awarded on October 30, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical and medical supply contracts. The company's IDC with DLA functions as a global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide. All of AmerisourceBergen's reviewed federal contract awards have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements. The DLA Troop Support Medical contract supports customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 10/30/25 |